Lam Research (NASDAQ:LRCX) Stock Price Expected to Rise, Morgan Stanley Analyst Says

Lam Research (NASDAQ:LRCXGet Free Report) had its price target hoisted by stock analysts at Morgan Stanley from $331.00 to $404.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the semiconductor company’s stock. Morgan Stanley’s price target points to a potential upside of 11.77% from the stock’s previous close.

LRCX has been the subject of a number of other research reports. Barclays reissued an “overweight” rating and issued a $335.00 price objective (up from $275.00) on shares of Lam Research in a report on Thursday, June 11th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Lam Research from $300.00 to $325.00 and gave the company a “buy” rating in a research report on Thursday, April 23rd. UBS Group reiterated a “buy” rating and issued a $375.00 price target (up from $310.00) on shares of Lam Research in a research note on Tuesday, June 9th. Seaport Research Partners initiated coverage on Lam Research in a research report on Monday, May 4th. They set a “buy” rating and a $300.00 price target on the stock. Finally, Sanford C. Bernstein raised their price objective on Lam Research from $325.00 to $340.00 and gave the stock an “outperform” rating in a research note on Thursday, May 21st. Twenty-eight research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $347.75.

View Our Latest Analysis on Lam Research

Lam Research Stock Performance

LRCX opened at $361.45 on Monday. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.54 and a quick ratio of 1.77. The business has a fifty day simple moving average of $326.35 and a 200 day simple moving average of $258.02. Lam Research has a 1 year low of $90.93 and a 1 year high of $438.50. The company has a market capitalization of $452.02 billion, a PE ratio of 68.59, a price-to-earnings-growth ratio of 2.10 and a beta of 1.80.

Lam Research (NASDAQ:LRCXGet Free Report) last posted its quarterly earnings data on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.11. The firm had revenue of $5.84 billion for the quarter, compared to analysts’ expectations of $5.70 billion. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.The company’s quarterly revenue was up 23.8% compared to the same quarter last year. During the same quarter last year, the business earned $1.04 EPS. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. Research analysts expect that Lam Research will post 5.68 EPS for the current year.

Insider Transactions at Lam Research

In related news, Director Eric Brandt sold 54,500 shares of Lam Research stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total value of $19,118,600.00. Following the transaction, the director directly owned 199,205 shares of the company’s stock, valued at $69,881,114. This trade represents a 21.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Ava Harter sold 6,010 shares of the company’s stock in a transaction on Monday, April 27th. The stock was sold at an average price of $258.66, for a total value of $1,554,546.60. Following the sale, the insider owned 53,205 shares of the company’s stock, valued at $13,762,005.30. The trade was a 10.15% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 86,339 shares of company stock valued at $27,680,267. Company insiders own 0.31% of the company’s stock.

Institutional Trading of Lam Research

Institutional investors have recently made changes to their positions in the company. Fideuram Asset Management Ireland dac purchased a new position in shares of Lam Research in the 4th quarter worth about $10,035,000. Generali Investments Management Co LLC raised its position in Lam Research by 62.0% in the fourth quarter. Generali Investments Management Co LLC now owns 36,274 shares of the semiconductor company’s stock worth $6,209,000 after acquiring an additional 13,878 shares during the period. Krilogy Financial LLC boosted its stake in Lam Research by 19.5% in the first quarter. Krilogy Financial LLC now owns 28,111 shares of the semiconductor company’s stock valued at $6,006,000 after acquiring an additional 4,584 shares during the last quarter. Y Intercept Hong Kong Ltd purchased a new position in Lam Research in the first quarter valued at about $26,489,000. Finally, Whalen Wealth Management Inc. bought a new position in shares of Lam Research during the 4th quarter valued at approximately $1,423,000. Institutional investors own 84.61% of the company’s stock.

About Lam Research

(Get Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

See Also

Analyst Recommendations for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.